Article thumbnail

CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions

By Richard D. Smith, James B. Dunbar, Peter Man-Un Ung, Emilio X. Esposito, Chao-Yie Yang, Shaomeng Wang and Heather A. Carlson
Publisher: American Chemical Society
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). 2.2.5; OpenEye Scientific Software, Inc.:
  2. (2006). A critical assessment of docking programs and scoring functions.
  3. (2011). A unified, probabilistic framework for structure- and ligand-based virtual screening.
  4. (2006). An iterative knowledge-based scoring function to predict protein-ligand interactions: I. Derivation of interaction potentials.
  5. (2006). and propertybaseddesignoffactorXainhibitors:pyrrolidin-2-oneswithacyclicalanyl amides as P4 motifs.
  6. (2008). Application of belief theory to similarity data fusion for use in analog searching and lead
  7. (2002). Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors.
  8. (2006). Arylsulfonamides:astudyoftherelationshipbetweenactivityandconformational preferences for a series of factor Xa inhibitors.
  9. (2008). ASEDockdocking based on alpha spheres and excluded volumes.
  10. (2006). Benchmarking sets for molecular docking.
  11. (2008). Binding MOAD, a high-quality protein-ligand database. Nucleic Acids Res.
  12. (2010). Books of Abstracts; 240th American Chemical Society National Meeting,
  13. (2008). Build_model; version 2.0.1 build 07.30; MolTech Ltd.:
  14. (2011). Cheminformatic tools for medicinal chemists.
  15. (2006). Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexes.
  16. (2002). ConsDock: A new program for the consensus analysisofprotein-ligandinteractions.
  17. (2005). Consensus scoring criteria for improving enrichment in virtual screening.
  18. (2002). Consensus scoring for ligand/protein interactions.
  19. (2006). Consensus scoring for protein-ligand interactions. Drug Discovery Today
  20. (2008). Consensus scoring with feature selection for structure-based virtual screening.
  21. (1999). Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.
  22. (2011). CSAR Benchmark Exercise of2010: Selectionof the protein-ligand complexes.
  23. (2005). database: methodologies and updates.
  24. (2006). Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors.
  25. (2008). Design of multi-bindingsite inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
  26. (1999). Determinants of ligand binding to cAMP-dependent protein kinase. Biochemistry
  27. (2008). Differences between high- and low-affinity complexes of enzymes and nonenzymes.
  28. (1996). Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4.
  29. (2007). eHiTS: a new fast, exhaustive flexible ligand docking system.
  30. (2011). Evaluation of Several Two-step Scoring Functions Based on Linear Interaction Energy, Effective Ligand Size, and Empirical Pair Potentials for Prediction of Protein-Ligand Binding Geometry
  31. (1997). Experimental and Compoutational Approaches to Estimate Solubility and Permeability
  32. (2006). Exploring protein-ligand recognition with Binding
  33. (2006). GFscore: a general nonlinear consensus scoring function for highthroughput docking.
  34. (2004). Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
  35. (2011). Global free energy scoring functions based on distance-dependent atom-type pair descriptors.
  36. Healthy skepticism:assessingrealisticmodelperformance.DrugDiscoveryToday2009, 14, 420–427.2131 |J.
  37. (2001). How does consensus scoring work for virtuallibraryscreening?Anidealizedcomputerexperiment.J.Chem.Inf.
  38. (1999). Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis.
  39. (2004). Impact of scoring functions on enrichment in docking-based virtual screening: an application study on renin inhibitors.
  40. (2003). Improved protein-ligand docking using GOLD. Proteins: Struct.,
  41. (2004). Kirsch,J.F.Narrowingsubstratespecificityinadirectlyevolvedenzyme: the A293D mutant of aspartate aminotransferase. Biochemistry
  42. (2000). Knowledge-based scoring function to predict protein-ligand interactions.
  43. (2008). Lead finder: an approach to improve accuracy of proteinligand docking, binding energy estimation, and virtual
  44. (2006). Ligand bias of scoring functions in structure-based virtual screening.
  45. (2006). M-score: a knowledge-based potential scoring function accounting for protein atom mobility.
  46. (2008). Maximum common binding modes (MCBM): consensus docking scoring using multiple ligand information and interaction fingerprints.
  47. (2008). MedusaScore: an accurate force field-based scoring function for virtual drug screening.
  48. (1992). Molecular Docking Using Shape Descriptors.
  49. (2010). Molecular Operating Environment (MOE); version 2010.10; Chemical Computing Group:
  50. (2007). MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res.
  51. (2004). Murray,C.W.;Taylor,R.D.;Watson,P.Virtualscreeningusingproteinligand docking: avoiding artificial enrichment.
  52. (2002). Parametrization of a force field for metals complexed to biomacromolecules: applications to Fe(II), Cu(II)
  53. (1999). Prediction of physicochemical parameters by atomic contributions.
  54. (2006). Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.
  55. (2002). PRO_SELECT:combiningstructure-baseddrugdesignandarray-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
  56. Probability and Statistical Inference;
  57. (2005). Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray
  58. (2000). Property distribution of drug-related chemical databases.
  59. (2000). Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/ scoring combinations.
  60. (2007). Protonation changes upon ligand binding to trypsin and thrombin: structural interpretation based on pKa calculations and ITC
  61. (2007). Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues.
  62. (2010). QM/MM X-ray refinement of zinc metalloenzymes.
  63. (2007). R.M.;Wexler,R.R.;Lam,P.Y.SARandX-raystructuresofenantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa.
  64. (2005). Recent advances in docking and scoring. Curr. Comput.-Aided Drug Des.
  65. (2000). Sample Size Requirements for Estimating Pearson, Kendall and Spearman Correlatons. Psychometrika
  66. (2007). Selective and dual action orally active inhibitors of thrombin and factor
  67. (2009). SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
  68. (2010). Software News and Update AutoDock Vina:ImprovingtheSpeedandAccuracyofDockingwithaNewScoring Function,
  69. (2007). Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space.
  70. (2008). Structure-based virtual screening with supervised consensus scoring: evaluation of pose prediction and enrichment factors.
  71. (2004). The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures.
  72. (2006). The use of consensus scoring in ligand-based virtual screening.
  73. (2002). Thermodynamic Quantities for the Ionization Reactions of Buffers.
  74. (2007). Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
  75. (2009). version 2.9.2; R Project for Statistical Computing:
  76. (2010). version 9.0.0;
  77. (2005). Virtual screening against metalloenzymesforinhibitors andsubstrates. Biochemistry
  78. (2004). Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors.
  79. (1999). W.Remarks about proteinstructure precision. Acta Crystallogr. D
  80. Wang,R.;Lai,L.;Wang,S.Furtherdevelopmentandvalidation of empirical scoring functions for structure-based binding affinity prediction.
  81. (2003). Wang,S.Comparative evaluation of11scoring functions for molecular docking.
  82. Warfarin and the vitamin K-dependentgamma-carboxylationsystem.TrendsMol.Med.2004,10,299–302.
  83. (1990). WHAT IF: a molecular modeling and drug design program.
  84. (2008). Y.Amethodtoenhancethehitratiobyacombinationofstructure-based drug screening and ligand-based screening.